NFKB1 and cancer: The ability of n-3 LC-PUFA to regulate oncogene transcription factors has also been described, including, for example, decreased nuclear factor-kappa B (Nf-kB) activity making n-3 LC-PUFA potentially useful adjunctive cancer therapy agents by sensitizing tumor cells to chemotherapy and promoting apoptosis [56].